Skip to main content
. 2022 Mar 24;17:178. doi: 10.1186/s13018-022-03070-z

Table 3.

The outcomes of patients in the two groups

Non-ERAS (n = 540) ERAS (n = 540) p value

Wound complications, n(%)

SSI, n(%)

Wound dehiscence, p n(%)

Persist wound drainage, n(%)

94 (17.8%)

21 (4.0%)

33 (6.0%)

40 (7.5%)

66 (12.4%)

16 (3.0%)

17 (3.0%)

33 (6.2%)

p = 0.02*

p = 0.40

p = 0.02*

p = 0.39

Other complications
 Cardiovascular disease 5 (1%) 5 (1%) p = 1.00
 Acute cerebral infarction 3 (0.6%) 3 (0.6%) p = 1.00
 Pneumonia 9 (1.7%) 6 (1.0%) p = 0.44
 Hematoma 6 (1.0%) 4 (0.8%) p = 0.53
 DVT 7 (1.2%) 5 (1.0%) p = 0.56
 Urinary tract infection 11 (2.0%) 4 (0.8%) p = 0.07

 Hypoalbuminemia

 Server hypoalbuminemia

267 (50.4%)

84 (15.8%)

242 (45.7%)

48 (9.0%)

p = 0.12

p < 0.01*

 Albumin infusion 152 (28.6%) 39 (7.4%) p < 0.01*
 Preoperative LOS(d) 5.70.8 5.50.7 p = 0.32
 Postoperative LOS(d) 9.51.7 8.01.5 p < 0.01*
 Rate of readmission 34 (6.4%) 10 (1.9%) p < 0.01*
 Discharge to rehabilitation center, n(%) 22 (4.2%) 5 (1.0%) p < 0.01*

SSI: surgical site infection; DVT: deep venous thrombosis; LOS: the length of stay